table of content
1 Introduction to Research & Analysis Reports
1.1 Neoantigen Cancer Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neoantigen Cancer Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neoantigen Cancer Vaccine Overall Market Size
2.1 Global Neoantigen Cancer Vaccine Market Size: 2022 VS 2030
2.2 Global Neoantigen Cancer Vaccine Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neoantigen Cancer Vaccine Players in Global Market
3.2 Top Global Neoantigen Cancer Vaccine Companies Ranked by Revenue
3.3 Global Neoantigen Cancer Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Neoantigen Cancer Vaccine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neoantigen Cancer Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neoantigen Cancer Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Neoantigen Cancer Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Neoantigen Cancer Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neoantigen Cancer Vaccine Market Size Markets, 2022 & 2030
4.1.2 Personalized Vaccine
4.1.3 Off-the-shelf Neovaccines
4.2 By Type - Global Neoantigen Cancer Vaccine Revenue & Forecasts
4.2.1 By Type - Global Neoantigen Cancer Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Neoantigen Cancer Vaccine Revenue, 2024-2030
4.2.3 By Type - Global Neoantigen Cancer Vaccine Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neoantigen Cancer Vaccine Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Neoantigen Cancer Vaccine Revenue & Forecasts
5.2.1 By Application - Global Neoantigen Cancer Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Neoantigen Cancer Vaccine Revenue, 2024-2030
5.2.3 By Application - Global Neoantigen Cancer Vaccine Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Neoantigen Cancer Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Neoantigen Cancer Vaccine Revenue & Forecasts
6.2.1 By Region - Global Neoantigen Cancer Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Neoantigen Cancer Vaccine Revenue, 2024-2030
6.2.3 By Region - Global Neoantigen Cancer Vaccine Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Neoantigen Cancer Vaccine Revenue, 2018-2030
6.3.2 US Neoantigen Cancer Vaccine Market Size, 2018-2030
6.3.3 Canada Neoantigen Cancer Vaccine Market Size, 2018-2030
6.3.4 Mexico Neoantigen Cancer Vaccine Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Neoantigen Cancer Vaccine Revenue, 2018-2030
6.4.2 Germany Neoantigen Cancer Vaccine Market Size, 2018-2030
6.4.3 France Neoantigen Cancer Vaccine Market Size, 2018-2030
6.4.4 U.K. Neoantigen Cancer Vaccine Market Size, 2018-2030
6.4.5 Italy Neoantigen Cancer Vaccine Market Size, 2018-2030
6.4.6 Russia Neoantigen Cancer Vaccine Market Size, 2018-2030
6.4.7 Nordic Countries Neoantigen Cancer Vaccine Market Size, 2018-2030
6.4.8 Benelux Neoantigen Cancer Vaccine Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Neoantigen Cancer Vaccine Revenue, 2018-2030
6.5.2 China Neoantigen Cancer Vaccine Market Size, 2018-2030
6.5.3 Japan Neoantigen Cancer Vaccine Market Size, 2018-2030
6.5.4 South Korea Neoantigen Cancer Vaccine Market Size, 2018-2030
6.5.5 Southeast Asia Neoantigen Cancer Vaccine Market Size, 2018-2030
6.5.6 India Neoantigen Cancer Vaccine Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Neoantigen Cancer Vaccine Revenue, 2018-2030
6.6.2 Brazil Neoantigen Cancer Vaccine Market Size, 2018-2030
6.6.3 Argentina Neoantigen Cancer Vaccine Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neoantigen Cancer Vaccine Revenue, 2018-2030
6.7.2 Turkey Neoantigen Cancer Vaccine Market Size, 2018-2030
6.7.3 Israel Neoantigen Cancer Vaccine Market Size, 2018-2030
6.7.4 Saudi Arabia Neoantigen Cancer Vaccine Market Size, 2018-2030
6.7.5 UAE Neoantigen Cancer Vaccine Market Size, 2018-2030
7 Neoantigen Cancer Vaccine Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Neoantigen Cancer Vaccine Major Product Offerings
7.1.4 Roche Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Medimmune
7.2.1 Medimmune Company Summary
7.2.2 Medimmune Business Overview
7.2.3 Medimmune Neoantigen Cancer Vaccine Major Product Offerings
7.2.4 Medimmune Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.2.5 Medimmune Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Neoantigen Cancer Vaccine Major Product Offerings
7.3.4 Merck Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Advaxis
7.4.1 Advaxis Company Summary
7.4.2 Advaxis Business Overview
7.4.3 Advaxis Neoantigen Cancer Vaccine Major Product Offerings
7.4.4 Advaxis Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.4.5 Advaxis Key News & Latest Developments
7.5 Agenus
7.5.1 Agenus Company Summary
7.5.2 Agenus Business Overview
7.5.3 Agenus Neoantigen Cancer Vaccine Major Product Offerings
7.5.4 Agenus Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.5.5 Agenus Key News & Latest Developments
7.6 Genocea
7.6.1 Genocea Company Summary
7.6.2 Genocea Business Overview
7.6.3 Genocea Neoantigen Cancer Vaccine Major Product Offerings
7.6.4 Genocea Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.6.5 Genocea Key News & Latest Developments
7.7 Gritstone Oncology
7.7.1 Gritstone Oncology Company Summary
7.7.2 Gritstone Oncology Business Overview
7.7.3 Gritstone Oncology Neoantigen Cancer Vaccine Major Product Offerings
7.7.4 Gritstone Oncology Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.7.5 Gritstone Oncology Key News & Latest Developments
7.8 Neon Therapeutics
7.8.1 Neon Therapeutics Company Summary
7.8.2 Neon Therapeutics Business Overview
7.8.3 Neon Therapeutics Neoantigen Cancer Vaccine Major Product Offerings
7.8.4 Neon Therapeutics Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.8.5 Neon Therapeutics Key News & Latest Developments
7.9 Nouscom
7.9.1 Nouscom Company Summary
7.9.2 Nouscom Business Overview
7.9.3 Nouscom Neoantigen Cancer Vaccine Major Product Offerings
7.9.4 Nouscom Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.9.5 Nouscom Key News & Latest Developments
7.10 OSE Immunotherapeutics
7.10.1 OSE Immunotherapeutics Company Summary
7.10.2 OSE Immunotherapeutics Business Overview
7.10.3 OSE Immunotherapeutics Neoantigen Cancer Vaccine Major Product Offerings
7.10.4 OSE Immunotherapeutics Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.10.5 OSE Immunotherapeutics Key News & Latest Developments
7.11 Medigene
7.11.1 Medigene Company Summary
7.11.2 Medigene Business Overview
7.11.3 Medigene Neoantigen Cancer Vaccine Major Product Offerings
7.11.4 Medigene Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.11.5 Medigene Key News & Latest Developments
7.12 Vaccibody
7.12.1 Vaccibody Company Summary
7.12.2 Vaccibody Business Overview
7.12.3 Vaccibody Neoantigen Cancer Vaccine Major Product Offerings
7.12.4 Vaccibody Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.12.5 Vaccibody Key News & Latest Developments
7.13 Brightpath Biotherapeutics
7.13.1 Brightpath Biotherapeutics Company Summary
7.13.2 Brightpath Biotherapeutics Business Overview
7.13.3 Brightpath Biotherapeutics Neoantigen Cancer Vaccine Major Product Offerings
7.13.4 Brightpath Biotherapeutics Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.13.5 Brightpath Biotherapeutics Key News & Latest Developments
7.14 Geneos Therapeutics
7.14.1 Geneos Therapeutics Company Summary
7.14.2 Geneos Therapeutics Business Overview
7.14.3 Geneos Therapeutics Neoantigen Cancer Vaccine Major Product Offerings
7.14.4 Geneos Therapeutics Neoantigen Cancer Vaccine Revenue in Global Market (2018-2023)
7.14.5 Geneos Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
